Improving fat grafts for breast reconstruction
A recombinant matrix to improve autologous tissue grafts
['FUNDING_SBIR_2'] · INSOMA BIO, INC. · NIH-10652973
This study is working on a new way to make fat grafting for breast reconstruction after cancer treatment even better, so that it can be a safer and more effective option than traditional breast implants.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INSOMA BIO, INC. (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10652973 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new tissue matrix that enhances the effectiveness of autologous fat grafting in breast reconstructive surgery. The goal is to provide a safer and more accessible alternative to traditional breast implants, which have raised concerns regarding long-term health effects. By addressing the limitations of current fat grafting techniques, this project aims to improve the outcomes for patients undergoing breast reconstruction after cancer treatment. The approach involves refining the methods of fat harvesting and grafting to ensure better structural integrity and usability of the fat tissue.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors seeking reconstructive surgery who prefer alternatives to implants.
Not a fit: Patients who do not have sufficient fat tissue available for grafting or those who are not undergoing breast reconstruction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide breast cancer patients with a safer and more effective option for breast reconstruction.
How similar studies have performed: Previous studies have shown promise in improving fat grafting techniques, but this specific approach is innovative and aims to address existing challenges in the field.
Where this research is happening
DURHAM, UNITED STATES
- INSOMA BIO, INC. — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROBERTS, STEFAN — INSOMA BIO, INC.
- Study coordinator: ROBERTS, STEFAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.